TNDM logo

Tandem Diabetes Care (TNDM) EBITDA

Annual EBITDA

-$196.97 M
-$122.77 M-165.43%

December 31, 2023


Summary


Performance

TNDM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTNDMprofitabilitymetrics:

Quarterly EBITDA

-$16.54 M
+$7.30 M+30.64%

September 30, 2024


Summary


Performance

TNDM Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTNDMprofitabilitymetrics:

TTM EBITDA

-$100.80 M
+$6.03 M+5.64%

September 30, 2024


Summary


Performance

TNDM TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTNDMprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

TNDM EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-165.4%+36.6%+48.7%
3 y3 years-1340.1%+42.5%+50.1%
5 y5 years-80.4%+42.5%+50.1%

TNDM EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-678.3%at low-205.0%+86.1%-396.0%+50.1%
5 y5-year-678.3%at low-166.2%+86.1%-332.8%+50.1%
alltimeall time-678.3%at low-166.2%+86.1%-332.8%+50.1%

Tandem Diabetes Care EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$16.54 M(-30.6%)
-$100.80 M(-5.6%)
Jun 2024
-
-$23.84 M(-30.6%)
-$106.83 M(-4.4%)
Mar 2024
-
-$34.34 M(+31.7%)
-$111.75 M(-43.1%)
Dec 2023
-$196.97 M(+165.4%)
-$26.08 M(+15.6%)
-$196.52 M(+8.1%)
Sep 2023
-
-$22.57 M(-21.5%)
-$181.83 M(-10.0%)
Jun 2023
-
-$28.76 M(-75.9%)
-$202.03 M(+11.3%)
Mar 2023
-
-$119.11 M(+945.4%)
-$181.59 M(+144.7%)
Dec 2022
-$74.21 M(-317.9%)
-$11.39 M(-73.4%)
-$74.21 M(+57.7%)
Sep 2022
-
-$42.76 M(+414.0%)
-$47.07 M(-882.2%)
Jun 2022
-
-$8.32 M(-29.1%)
$6.02 M(-73.7%)
Mar 2022
-
-$11.73 M(-174.5%)
$22.92 M(-32.7%)
Dec 2021
$34.06 M(-349.0%)
$15.74 M(+52.5%)
$34.06 M(-21.4%)
Sep 2021
-
$10.33 M(+20.3%)
$43.31 M(+38.8%)
Jun 2021
-
$8.59 M(-1536.0%)
$31.21 M(-2436.2%)
Mar 2021
-
-$598.00 K(-102.4%)
-$1.34 M(-90.2%)
Dec 2020
-$13.68 M(-26.2%)
$24.99 M(-1512.7%)
-$13.68 M(-60.1%)
Sep 2020
-
-$1.77 M(-92.6%)
-$34.30 M(+1.3%)
Jun 2020
-
-$23.96 M(+85.2%)
-$33.87 M(+241.9%)
Mar 2020
-
-$12.94 M(-396.0%)
-$9.91 M(-46.5%)
Dec 2019
-$18.53 M(-83.0%)
$4.37 M(-425.0%)
-$18.52 M(+4.6%)
Sep 2019
-
-$1.34 M(<-9900.0%)
-$17.70 M(-62.9%)
Jun 2019
-
$5000.00(-100.0%)
-$47.75 M(-53.5%)
Mar 2019
-
-$21.55 M(-515.7%)
-$102.60 M(-6.0%)
Dec 2018
-$109.18 M
$5.18 M(-116.5%)
-$109.18 M(-9.6%)
Sep 2018
-
-$31.39 M(-42.8%)
-$120.73 M(+19.9%)
DateAnnualQuarterlyTTM
Jun 2018
-
-$54.84 M(+95.0%)
-$100.73 M(+59.4%)
Mar 2018
-
-$28.13 M(+341.4%)
-$63.21 M(+15.3%)
Dec 2017
-$54.82 M(-24.1%)
-$6.37 M(-44.0%)
-$54.82 M(-9.1%)
Sep 2017
-
-$11.39 M(-34.3%)
-$60.28 M(-20.7%)
Jun 2017
-
-$17.32 M(-12.3%)
-$75.98 M(+2.4%)
Mar 2017
-
-$19.74 M(+66.8%)
-$74.22 M(+2.7%)
Dec 2016
-$72.27 M(+13.2%)
-$11.84 M(-56.3%)
-$72.27 M(+2.7%)
Sep 2016
-
-$27.08 M(+74.0%)
-$70.34 M(+15.9%)
Jun 2016
-
-$15.56 M(-12.5%)
-$60.68 M(-2.9%)
Mar 2016
-
-$17.79 M(+79.5%)
-$62.49 M(-2.1%)
Dec 2015
-$63.84 M(-10.3%)
-$9.91 M(-43.1%)
-$63.84 M(-8.9%)
Sep 2015
-
-$17.42 M(+0.2%)
-$70.09 M(-0.6%)
Jun 2015
-
-$17.38 M(-9.2%)
-$70.48 M(+0.1%)
Mar 2015
-
-$19.13 M(+18.3%)
-$70.39 M(-1.1%)
Dec 2014
-$71.16 M(+28.8%)
-$16.17 M(-9.2%)
-$71.16 M(-7.3%)
Sep 2014
-
-$17.81 M(+3.0%)
-$76.74 M(+9.6%)
Jun 2014
-
-$17.29 M(-13.1%)
-$70.03 M(+6.2%)
Mar 2014
-
-$19.90 M(-8.5%)
-$65.95 M(+19.3%)
Dec 2013
-$55.26 M(+94.2%)
-$21.74 M(+95.9%)
-$55.26 M(+34.0%)
Sep 2013
-
-$11.10 M(-16.0%)
-$41.23 M(+14.6%)
Jun 2013
-
-$13.21 M(+43.4%)
-$35.97 M(+58.0%)
Mar 2013
-
-$9.21 M(+19.5%)
-$22.76 M(+68.0%)
Dec 2012
-$28.46 M(+20.1%)
-$7.71 M(+31.9%)
-$13.55 M(+131.9%)
Sep 2012
-
-$5.84 M
-$5.84 M
Dec 2011
-$23.69 M
-
-

FAQ

  • What is Tandem Diabetes Care annual EBITDA?
  • What is the all time high annual EBITDA for Tandem Diabetes Care?
  • What is Tandem Diabetes Care annual EBITDA year-on-year change?
  • What is Tandem Diabetes Care quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Tandem Diabetes Care?
  • What is Tandem Diabetes Care quarterly EBITDA year-on-year change?
  • What is Tandem Diabetes Care TTM EBITDA?
  • What is the all time high TTM EBITDA for Tandem Diabetes Care?
  • What is Tandem Diabetes Care TTM EBITDA year-on-year change?

What is Tandem Diabetes Care annual EBITDA?

The current annual EBITDA of TNDM is -$196.97 M

What is the all time high annual EBITDA for Tandem Diabetes Care?

Tandem Diabetes Care all-time high annual EBITDA is $34.06 M

What is Tandem Diabetes Care annual EBITDA year-on-year change?

Over the past year, TNDM annual EBITDA has changed by -$122.77 M (-165.43%)

What is Tandem Diabetes Care quarterly EBITDA?

The current quarterly EBITDA of TNDM is -$16.54 M

What is the all time high quarterly EBITDA for Tandem Diabetes Care?

Tandem Diabetes Care all-time high quarterly EBITDA is $24.99 M

What is Tandem Diabetes Care quarterly EBITDA year-on-year change?

Over the past year, TNDM quarterly EBITDA has changed by +$9.54 M (+36.59%)

What is Tandem Diabetes Care TTM EBITDA?

The current TTM EBITDA of TNDM is -$100.80 M

What is the all time high TTM EBITDA for Tandem Diabetes Care?

Tandem Diabetes Care all-time high TTM EBITDA is $43.31 M

What is Tandem Diabetes Care TTM EBITDA year-on-year change?

Over the past year, TNDM TTM EBITDA has changed by +$95.72 M (+48.71%)